Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02325531 · ClinicalTrials.gov registry record · NA
SPREAD-NET: PRactices Enabling Adapting and Disseminating in the Safety NET
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 166
- Enrollment target
NCT02325531 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 166 participants.
The verdict
NCT02325531, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 166 participants
- Enrollment target
Study Summary
The investigators propose to compare the effectiveness of 3 strategies (low, medium, high intensity) at supporting CHCs' implementation of the ALL Initiative (an intervention shown to reduce patients' cardiovascular disease (CVD) event risk), through a cluster-randomized trial.
Interventions
- OTHER Low support
- OTHER Medium support
- OTHER High support
- OTHER Comparison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2014-09 |
| Est. Completion | 2021-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02325531
The ClinicalTrials.gov registry entry for NCT02325531 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Low support is the first listed.
NCT02325531 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02325531 about?
NCT02325531 is a clinical study titled "SPREAD-NET: PRactices Enabling Adapting and Disseminating in the Safety NET". The investigators propose to compare the effectiveness of 3 strategies (low, medium, high intensity) at supporting CHCs' implementation of the ALL Initiative (an intervention shown to reduce patients' cardiovascular disease (CVD) event risk), through a cluster-randomized trial.
What is the current status of trial NCT02325531?
This trial is currently completed. It is a NA study. The enrollment target is 166 participants. The study started on 2014-09. Estimated completion is 2021-08.
What interventions are being tested in trial NCT02325531?
The interventions under investigation include: Low support (OTHER), Medium support (OTHER), High support (OTHER), Comparison (OTHER).
Who is sponsoring clinical trial NCT02325531?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.